Global

Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy

Migraine Prevention Gets a Wider Door

Indigenous cardiovascular inequity is not a data gap. It is a policy failure

Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate

MS Regulators Are No Longer Reading the Same Risk

NTDs Are Now A Human-Rights Issue. Budgets Must Follow.

Cardiology has too many dashboards. The danger is forgetting the patient

GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up

ALS Needs Proof, Not Just Another Biomarker
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
